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The suppr~siv¢ and cytotoxi= of reefs of intcrlcukin.10 (IL.10} on rodent insulin-producing cells observcd in vitro are probably mediated through 
formation of nitric oxide (NO). In this study we demonstrate that [L,I.induced NO formation in isolated rat islets and insulin-producing HIT cells 
is more sensitive to inhibition by ~;-monon'~¢thyl.t..arginine than to inhibition by N';-nitro-L.arginine, thus suggesting that [ L.I,.¢xpo=h~l insulin. 
producing cells express an isoform o1' nit ric oxide synth.'t= similar to that present in activated macropltages, Furthermore, I L-I.~ markedly increased 
the mRNA levels o1" the inducible m;tcrophag¢ fern1 of nitric oxide syntha~ in HIT cells, 
interleukin.l,8: Nitric oxide: Nitric oxide synthas=; l~n,:reatic islet: HIT cell: In,~ulin-dcpendent dia~tcs mellitus 
1, INTRODUCTION 
Following the origin.'tl description of the suppressive 
and c~ totoxic effects of the cytokine interleukin- 1(l L-I) 
on rodent pancreatic B-cells [|1, there has been a contin- 
uous effort to unveil the mechanisms behind these ac- 
tions of IL-I [2]. Recent data suggest hat the actions of 
the cytokine initiates with binding to membrane recep- 
tors [3,4], induction of gene transcription and protein 
translation [5,6]. This is followed by a progressive accu- 
mulation of the radical nitric oxide [7-10]. which may 
impair the activity of the Kreb's cycle enzynt= ~,conitase 
[8] and thus lead to a decrease in mitochondrial function 
and ATP production [11,I 2], 
There are different isoforms of the enzyme NO syn- 
these in distinct tissues [13]. The best characterised 
isoforms are the ones present in endothelial cells/neu- 
rons [14] or in activated macrophages [l 5.I6]. They dif- 
fer in their sensitivity to inhibition by arginine ana- 
logue)., cofactor requirements and parts of their de- 
duced amino acid sequence [13-16]. It still remains to 
be determined which form of NO synthase that is pres- 
ent ia pancreatic islets, In the present study we at- 
tempted to answer= this question by studying the inhib- 
itory effects of two different /Vz-substituted arginine 
derivatives on IL-l-induced nitrite generation, an end 
product of NO, in rat islets and in the cional insulin 
secretory line HIT-TI 5 cells (HIT cells) [17]. Moreover, 
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we also characterised the expression of mRNA for an 
inducible form of nitric oxide syntha~, recently cloned 
in marine macrophages [i5,16], in IL-l.a-exposed HIT 
cells, 
2. EXPERIMENTAL 
2. I. Materials 
Human recombinant IL-IB (rID.0) wax kindly provided by Dr, K, 
Bendtzen. Laboratory of Medi=l Immunology. Righo.,pitulet, 
Cola:nhugcn. i~nmark, Tl~e eytokin¢ was produced by Immuncx 
(Seattle, WA) and had a biological uctivity of 50 U/ng. as compared 
with an interim international standard rlL-.6 preparation (NIBSC. 
London, UK) titS], The chemicals were purchased from the followinlt 
g;  • sources,. A .mtro.t..;trginine and N%monomethyl.t..arslnina from 
Sigma Chenli~als Co (St. Louis. MO, USA): Fa~:tTrack mRNA i~la. 
tion Kit from Invitrol;en Corp. (San Diego, CA, USA.): MuhipHme 
DNA labelled system and [=-);F]dCTP from Anaersham International 
(Amersham, UK); MagnaOraph Nylon Tranffer Membrane from Mi- 
cron Separations Inc. (Wcstboro. MA, USA). All other chemi=ls ot" 
analytical grade were obtained from E, Merck (Damlastadt, Get. 
many), 
2.2. ltfetlmd~ 
Pancre.ati¢ slets were isolated by collal~nas¢ digestion front adult 
male Sprague-Dawley rats bred in u local colony (Uppsala, Sweden), 
The ¢lonal hamster insulin.secretory ¢=11 line HIT-T I 5 (HIT cells) [I 7] 
was originally obtained from Dr, S.J. A=ihcroft. Oxford, UK, The rat 
islets were cultured free.floating in medium RPMI 1640 containing 
11.1 mM glucose and supplemented with 10% (voUvol) FCS for 4-$ 
days ~l'ore exposure re riL.I/~ [19], Growing HIT cells were tryp=i- 
nized and subcuhured in RPMi 1640 supplemented with 10% (vol./vol) 
FCS, as previously describc.d [20], 
Exposure of rat islets or HIT cells to rlL-1~8 and/or the different 
arginine analogues was performed for 6, 12 or 24 h in medium RPMI 
1640, as describtd above, Followinj rlL-I,~ ¢aposure, aliquots of the 
culture me.dium (90/d) were deprotcinized and the nitrite content 
determined as recently dcscril:~r~d [Sl, 
Puhli,~hed by E.l,t'eri¢~' Science Pal)fishers B, V, 249 
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For Northern blot analysis, polytAl' ~,'ns isolated from 10' HIT 
¢'dls ttsinl~ u Fast'l'rack mgNA isolation kit. Pollov,'inl~ i~lation, lhc 
iml)'lA 1" ~tmplcs {S Ht~} wcrc ¢l~trophor¢~d on ;in a~t r~.~¢ i~1. trans- 
l'~rred onto a n)'h'm nlembrane [21}. and hybridized to a J'P.hlbclkd 
eDNA probe coding, for the inducible f~rm of nitric oxide synth:ts¢. 
recently cloned from a mttrin¢ nlaet'ophttll¢ call line [I ~l], I I>'hridiv;ttion 
und autor:tdiOl~raphy ,acre peformed as previously described 1211. 
Data are procnled ;is tn¢~¢n valuc~ + S.E.M,, -'rod groups of data 
were compared using paired or onpaired Student's t.leSt as ttppropri- 
;tie, 
3. RESULTS AND DISCUSSION 
As previously demonstrated [7--10]. nitrite produc- 
tion by rat pancreatic islets was strongly induced by 
rIL-l,,~ (Table I). The islet nitrite production in the ab- 
sence of IL-I/~ was low. :tnd was not affected by expo- 
sure to either 0.1. 1.0 or 2.0 mM Ard-rnonornethyl-I. - 
arginine (CH~-A) or/¢;-t~itro-L-arginine (NO.-A) (data 
not shown). NO,,-A. in concentrations up to 2 raM, 
f.'til.'d to sigrdficantly decrease nitrite production in- 
duced by riL-1,8 (Table I). On the other hand. the cytok- 
ine-stimuhtted nitrite accumulation was dose-depen- 
dently inhibited by CHs-A. When the etTeets o1" the N c;- 
inhibitors were assessed by recalcuhtting the data as % 
of control (100% being nitrite production by rat islets 
exposed to rlL-l,8 alone), CH~-A showed a significantly 
higher inhibitory action than NO..-A (Fig. 1). It has 
been previously shown that NO:-A displayed astriking 
selectivity for inhibition of brain .'tnd endothelial c¢11 
NO synthesis [22,23], while CH.~-A was rnostly effective 
against NO production by stimulated macrophuges 
[22,23]. Thus. the above described ata suggested that 
the I L-Ifl-responsive form of NO synthase present in rat 
islets was similar to that observed in cytokine-activated 
macrophages. 
The islets of l.amgerhans contuins an heterogeneous 
cell population, Even considering that the prolonged 
precultur¢ (4.-5 days) before rl L-I,B treatment m.'ty elim- 
inate rnost of the non-endocrine c lls in the islets, it can 
not be excluded that rIL-l,8 induces NO generation by 
non-endocrine islet cells. Indeed, it h:ts been recently 
suggested that the main source of cytokine-stimul:tted 
NO generation i pancreatic slets :ire endothelial cells. 
fibroblasts and/or resident macrophages [10]. To fur- 
ther study this issue, we tested the effects of rlL-1/~ 
and/or different NO synthase inhibitors on insulin.pro- 
ducing HIT cells. This cell line has been previously 
shown to posses IL-I surface receptors and to be sensi- 
tive to the inhibitory effects of the cytokine [3]. We 
observed that 1 ng/ml rlL-I.B induced a 40-50% de- 
crease in insulin accumulation i to the medium of HIT 
cells after 12-24 h (data not shown). As observed with 
rat islets, rlL-l,d induced a marked increase in nitrite 
accumulation over 12 h (Table II). This observation, 
together with recent data showing that rlL-ifl also in- 
duces nitrite production by the rat insulinoma cell line 
RINmSF [24], suggest hat insulin-producing cells c;tn 
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be, at least in part, the source of islet NO generation 
following exposure to rlL-l~. The basal production of 
nitrite was not affected by NO=-A or CHeA (data not 
shown), but both drugs inhibited in a dose-dependent 
way IL-lp.induced nitrite production (Table II). As ob. 
served in rut islets. CH:eA was more potent han NO..-A 
in inhibiting the effects of rlL-l~ on nitrite accumula- 
tion (Fig, 2). 
It has been previously suggested that rIL-lp-induced 
NO generation by pancreatic islets was secondary to 
activation of gene transcription [5,6]. Thus, we deter- 
mined whether lL-lp could induce gene expression of 
the macrophage form of NO synthase [15,16] in HIT 
cells. As shown in Fig. 3.6 or 24 h exposure of HIT cells 
to the cytokine induced a marked ¢xpre~ion of this 
mRNA. The transcript was 5.0 kb in lertgth, similar to 
observations in activated macrophag~ [l 5]. The finding 
that after 4 h (not shown) or 6 h (Fig. 3) of rlL-l# 
Table I 
EITcces of rlL-I# rind/or two dilTercnt arginine analogues on rat islet 
nitrite production 
rlL-l,# ~;.monommthyl. NtLnitro.t.-argin - Nitrite produ¢- 
(ng/ml) ~..:trginine (raM) ine (raM) tion (pmol islet x 
12 11) 
0 0 0 0.72 + 0.24"* 
1,0 0 0 .~,06 :t 1,04 
1.0 0 0,1 9,51~ ± 1,27 ' 
1,0 0 1,0 t146 _ u,91 
1,0 0 2,0 5.72 + 1,09 
1,0 0. I 0 ?,40 __. 0,62 
1.0 1.0 0 4,04 . 0,30" 
1.0 2.0 0 0.13 + 0,01]'" 
Rat islets in groups .ff lQ0 were cultured for 12 h witla or without 
rl L. Ip and different arginin¢ analogues, at,d d',e medlum liubsequemly 
taken for na¢-isurements of nitrite production, Results are expt'es,,ed 
of me. .  Z S,E,M. el" 4-8 expcrirnents, " and '* denote P < 0,01 and 
P < 0,001 when comparing vs, islets exposed to rlL.l/~ alone. 
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Fig, 2, Inhibition of nitrite accumulation by N%substitutcd arginin¢ 
analogs in HIT ~lls cxpo=d to rlL-I/~, HI P¢¢IIs were co,treated with 
riL-l,~ and the indicated conch|rations of urllinine analop, and the 
nitrite accumulation into the medium measured after 12 h, Rmiuhs arc 
means ± S.E.M, of 4-6 experiments. 'P < 0,0S and "'P -" 0.01 when 
¢ompurinp to HIT cells expo~d to NO...A, 
Ausust 1992 
1 2 3 4 
O 
exposure there was already induction of the mRNA. 
correlates well with the time-course of IL-I/~-induced 
nitrite production in isolated rat islets [8]. Control islets, 
or islets exposed to a non-specific stimulus (12-O- 
tetradccanoylphorpbol 13-acetate, TPA). did not show 
detectable l vels of the NO syntha~ mRNA. In another 
series of experiments (not shown), we also hybridi~d 5 
~g of poly(A)" obtained from HIT cells or from rat 
brain tissue with a eDNA encoding the brain form of 
nitric oxyde synthase [17] (the cDNA probe was a kind 
gift of Dr. S.H. Snyder, John Hopkins Medical Institu- 
tions. MA,  USA). In these experiments we observed a 
clear expression of the mRNA in the brain, but not in 
the HIT ~lls. As a whole, this and the above described 
data suggest that rlL-l,6 induces in insulin.producing 
cells the expression of a form of nitric oxyd¢ synthas¢ 
similar to that observed in activated macrophages. The 
Table I! 
Effects of rlL-1.O and/or two different arginine analogues on H1T<clIs 
nitrite production 
rlL.I/~ /W-nionon~.ethyb /W-nitro-L-at'gin- Nitrite 
(ng/ml) L.arginine (raM) ine (raM) production 
(pmoPIO" islet x 
12 h) 
0 0 0 2,26 +_ 0,29"'" 
1.0 0 0 15,64 :t: 2,02 
1.0 0 0,1 10,18 ± 1,10" 
1.0 0 1,0 6.06 _.% 0.90'" 
1.0 0 2,0 4,68 :J: 0.27"" 
1,0 0,1 0 7,27 4" 0,92" 
1.0 1,0 0 2.79 '*" 1.26"" 
1.0 2,0 0 0,52 4" 0.24 "° 
HIT cells (10 ~ ¢¢11s) wcrc cultured for 12 h with or without r lL - l :  and 
different arginine analogues, and the m~ium subsequently taken for 
measurement or nitrite production. Results are eapresP..d as means _+ 
S,E,M. of 4-6 ezperiments, " . "  and "'" denote respectively P < 0,05. 
P < 0,01 and P < 0.00I when comparing vs, H IT  cells exposed to 
rlL-lp alone. 
Fig. 3. Effects of rlL.-l.8 exposure on mRNA contenut of the mz~o- 
phage form of nitric oxide syntha~: in HIT cells. HIT o¢lls wgr¢ 
cxpog'd for 6 or 12 h to I ng/ml rlL.l#, or for 6 h to 100 nir/ml TPA 
and then harv~tcd for poly(A)* extraction, lime 1, control; lane 2, 
IL- 1 6 h: lane 3. IL.I 24 h; lane 4, TPA 6 h, The tigum is ~prc~ntativ= 
of 2 t~parate experiments, 
subsequent NO accumulation will lead to impairment 
in p-cell mitochondrial function [I 1,12], and eventually 
to cell damage [2]. 
Recent reports suggest hat inhibition of nitric oxide 
generation may prevent induction of streptozotodn-in- 
duced diabetes in mice [25,26]. The present characterisa- 
lion of the NO synthase form present in pancreatic 
3-cells may rahe new possibilities for an early ere.utreCht 
for insulin-dependent diabetes mellitus (IDDM). This 
could be achieved by the development of specific inhib- 
itors of the macrophage/fl.¢¢ll form on NO synthas¢, 
able to decrease cytokine-iaduced ~-cell damage with- 
out interfering with blood pressure control or neuro- 
transmission [24]. Clearly, extensive studies on the ef- 
fects of currently available inhibitors of NO generation 
on the evolution of spontaneous IDDM in rodents must 
be performed, in order to validate this hypothesis. 
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